KathleenGHalkaMD

Assistant Professor, Internal Medicine, Texas A&M Health Science Center College of Medicine

Dr. Halka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2401 S 31st St
Temple, TX 76508
Phone+1 254-724-2111

Fax+1 254-724-1530

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1983 - 1986
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1980 - 1983
Creighton University School of MedicineClass of 1980

PubMed

7 citations
A Case of Acquired Hemophilia A in a Patient with Exposure to COVID-19.
Jorge D Guerra, Jasmine Gowarty, Jordan Buess, James Mason, Kathleen Halka
Case Reports in Hematology. 2022-01-01
876 citations
Long-term safety and efficacy of factor IX gene therapy in hemophilia B
Amit C. Nathwani, Ulreke M Reiss, Edward G. D. Tuddenham, Cecilia Rosales, Pratima Chowdary
The New England Journal of Medicine. 2014-11-20
2 citations
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(
Nicole S Bartosh, Tara Tomlin, Christian Cable, Kathleen Halka
Clinical Pharmacology. 2013-03-15

Lectures

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018